# US 2026/0250744 A1 · Mutated v-type crispr enzyme and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0250744 A1
- Document ID: US20260250744A1
- Status: Published application
- Kind: A1
- Application number: 19/108,048
- Filed: 2023-08-29
- Published: 2026-08-27
- Earliest claimed: 2022-08-29
- Assignees: Beijing Synsortech Co., Ltd.; Zhejiang Synsorbio Technology Co., Ltd.; Beijing Synsorbio Technology Co., Ltd.; Zhejiang Synsorbio Gene Technology Co., Ltd.
- Applicants: Beijing Synsortech Co., Ltd.; Zhejiang Synsorbio Technology Co., Ltd.; Beijing Synsorbio Technology Co., Ltd.; Zhejiang Synsorbio Gene Technology Co., Ltd.
- Inventors: Weiye PAN; Yang SUN; Chongjjian CHEN; Pengyu ZHU; Shenghao YOU
- Web page: https://patentgrep.com/patent/US20260250744A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12Q 1/6823: Release of bound markers
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12Q 1/34: involving hydrolase
- C12Y 301/21001: Deoxyribonuclease I (3.1.21.1)
- C07K 2319/81: containing a Zn-finger domain for DNA binding
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- G01N 2333/922: Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided are a mutated V-type CRISPR enzyme and use thereof. By means of the protein mutation rational mutagenesis technology, the restriction on the recognition and cleavage of DNA substrates by RuvC in Cas12a or Cas12b is removed, so that RNA substrates can be efficiently recognized and cleaved, and the problem of insufficient RNA substrate recognition efficiency in practical applications is solved. The reaction efficiency of Cas12 with the RNA substrates after the activation of trans-cleavage activity is improved, and the reporting efficiency of Cas12 using an RNA probe is improved.

## Claims

### Claim 1

An engineered Cas12 protein or a functional derivative thereof, comprising the following mutations:
removing the restriction on the recognition and cleavage of DNA substrates by RuvC and/or Nuc active centers in a reference Cas12 protein,
preferably, the amino acid sequence of the reference Cas12 protein is represented by SEQ ID NO: 1.

### Claim 2 (depends on 1)

The engineered Cas12 protein or a functional derivative thereof according to claim 1, wherein removing the restriction on the recognition and cleavage of DNA substrates by RuvC and/or Nuc active centers in the reference Cas12 protein is achieved by:
replacing the fingers upstream and downstream of the α-helix of the gatekeeper amino acids in the reference Cas12 protein with zinc finger domains.

### Claim 3 (depends on 1)

The engineered Cas12 protein or a functional derivative thereof according to claim 1, wherein removing the restriction on the recognition and cleavage of DNA substrates by RuvC and/or Nuc active centers in the reference Cas12 protein is replacing the domains in part or all of the region in positions 915-945, wherein the amino acid position numbering is as defined in SEQ ID NO: 1.

### Claim 4 (depends on 2)

The engineered Cas12 protein or a functional derivative thereof according to claim 2, wherein the zinc finger domain has 1-2 zinc binding sites, and the zinc binding site is any one selected from the group consisting of: [CxxxxC], [CxxxxH], [CxxxC], [HxxxH], [CxxC] and [CxxH], wherein x represents any natural amino acid.

### Claim 5 (depends on 4)

The engineered Cas12 protein or a functional derivative thereof according to claim 4, wherein the zinc finger domain is a zinc finger domain of Cas12g or HIV-1 nucleocapsid protein 7 (Ncp7).

### Claim 6 (depends on 5)

The engineered Cas12 protein or a functional derivative thereof according to claim 5, wherein positions 919-944 of the reference Cas12 protein are replaced with the amino acid sequence represented by SEQ ID NO: 4, wherein the amino acid position numbering is as defined in SEQ ID NO: 1.

### Claim 7 (depends on 5)

The engineered Cas12 protein or a functional derivative thereof according to claim 5, wherein positions 919-944 of the reference Cas12 protein are replaced with the amino acid sequence represented by SEQ ID NO: 6, wherein the amino acid position numbering is as defined in SEQ ID NO: 1.

### Claim 8 (depends on 1)

The engineered Cas12 protein or a functional derivative thereof according to claim 1, wherein positions 919-944 of the reference Cas12 protein are replaced with the amino acid sequence represented by SEQ ID NO: 8, wherein the amino acid position numbering is as defined in SEQ ID NO: 1.

### Claim 9 (depends on 1)

The engineered Cas12 protein or a functional derivative thereof according to claim 1, wherein positions 916-944 of the reference Cas12 protein are replaced with the amino acid sequence represented by SEQ ID NO: 11, wherein the amino acid position numbering is as defined in SEQ ID NO: 1.

### Claim 10

An engineered Cas12 protein or a functional derivative thereof, comprising any one of the following mutations based on a reference Cas12 protein:
replacing positions 919-944 of the reference Cas12 protein with the amino acid sequence represented by SEQ ID NO: 4;
replacing positions 919-944 of the reference Cas12 protein with the amino acid sequence represented by SEQ ID NO: 6;
replacing positions 919-944 of the reference Cas12 protein with the amino acid sequence represented by SEQ ID NO: 8; and
replacing positions 916-944 of the reference Cas12 protein with the amino acid sequence represented by SEQ ID NO: 11;
wherein the amino acid sequence of the reference Cas12 protein is represented by SEQ ID NO: 1,
alternatively,
the sequence of the engineered Cas12 protein or a functional derivative thereof is an amino acid sequence represented by any one of SEQ ID NO: 5, 7, 9 or 12; or an amino acid sequence having 90% or more identity with the amino acid sequence represented by any one of SEQ ID NO: 5, 7, 9 or 12.

### Claim 11

(canceled)

### Claim 12 (depends on 1)

A detection system for detecting a target nucleic acid molecule, comprising:
the engineered Cas12 protein or a functional derivative thereof according to claim 1;
a guide RNA, wherein the guide RNA guides the Cas12 protein or a functional derivative thereof to specifically bind to a target nucleic acid molecule; and
a nucleic acid probe.

### Claim 13 (depends on 12)

The detection system according to claim 12, wherein the nucleic acid probe is an RNA probe.

### Claim 14 (depends on 1)

A method for detecting a target nucleic acid molecule in a sample, comprising:
contacting the sample with the engineered Cas12 protein or a functional derivative thereof according to claim 1, a guide RNA, and a target nucleic acid molecule; and
detecting the target nucleic acid molecule by measuring the detectable signal generated by cleavage of the nucleic acid probe by the engineered Cas12 protein or a functional derivative thereof.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the nucleic acid probe is an RNA probe.

### Claim 16

A detection system for selectively detecting a target nucleic acid molecule, comprising:
two or more Cas12 proteins or a functional derivative thereof having significant differences in cleavage specificity for RNA and DNA;
a guide RNA, wherein the guide RNA guides the Cas12 protein or a functional derivative thereof to specifically bind to the target nucleic acid molecule; and
a nucleic acid probe.

### Claim 17 (depends on 16)

The detection system according to claim 16, wherein at least one of the Cas12 proteins or the functional derivatives thereof is an engineered Cas12 protein or a functional derivative thereof, comprising the following mutations:
removing the restriction on the recognition and cleavage of DNA substrates by RuvC and/or Nuc active centers in a reference Cas12 protein,
preferably, the amino acid sequence of the reference Cas12 protein is represented by SEQ ID NO: 1.

### Claim 18 (depends on 17)

The detection system according to claim 17, wherein the nucleic acid probe is a DNA probe or an RNA probe.
